Form D · Biotechnology
Hypercell Technologies Inc.
Ithaca, NY · CIK 0001882357
Offering snapshot reported Oct 14, 2026 · SEC filing
- Reported sold
- $2.96M Offering amount: $4.42M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Sep 8, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 14, 2026 | Initial | $2,958,378 | No comparison | 14 | SEC filing |
| Sep 10, 2021 | Initial | $1,100,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-601095
Source: Form D, filed Oct 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Cali | Director |
| Loic De Blais | Executive |
| Sam Jactel | Director, Executive |
| Bruno Georges Jactel | Director, Executive |
| Samuel Jactel | Director, Executive |
| Tony Puri | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
95 Brown Rd.
Ithaca, NY, 14850
Phone: 4046618856
Ithaca, NY, 14850
Phone: 4046618856